CoChat

Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice

Open access
Amador, Ariadna, Bostick, Christopher D, Olson, Heather, Peters, Jurrian, Camp, Chad R, Krizay, Daniel, Chen, Wenjuan, Han, Wei, Tang, Weiting, Kanber, Ayla, Kim, Sukhan, Teoh, JiaJie, Sah, Megha, Petri, Sabrina, Paek, Hunki, Kim, Ana, Lutz, Cathleen M, Yang, Mu, Myers, Scott J, Bhattacharya, Subhrajit, Yuan, Hongjie, Goldstein, David B, Poduri, Annapurna, Boland, Michael J, Traynelis, Stephen F, Frankel, Wayne N · 2020 · Brain
Cited by 78

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

NMDA receptors play crucial roles in excitatory synaptic transmission. Rare variants in GRIN2A encoding the GluN2A subunit are associated with a spectrum of disorders, ranging from mild speech and language delay to intractable neurodevelopmental disorders, including but not limited to developmental and epileptic encephalopathy. A de novo missense variant, p.Ser644Gly, was identified in a child with this disorder, and Grin2a knock-in mice were generated to model and extend understanding of this intractable childhood disease. Homozygous and heterozygous mutant mice exhibited altered hippocampal morphology at 2 weeks of age, and all homozygotes exhibited lethal tonic-clonic seizures by mid-third week. Heterozygous adults displayed susceptibility to induced generalized seizures, hyperactivity, repetitive and reduced anxiety behaviours, plus several unexpected features, including significant resistance to electrically-induced limbic seizures and to pentylenetetrazole induced tonic-clonic seizures. Multielectrode recordings of neuronal networks revealed hyperexcitability and altered bursting and synchronicity. In heterologous cells, mutant receptors had enhanced NMDA receptor agonist potency and slow deactivation following rapid removal of glutamate, as occurs at synapses. NMDA receptor-mediated synaptic currents in heterozygous hippocampal slices also showed a prolonged deactivation time course. Standard anti-epileptic drug monotherapy was ineffective in the patient. Introduction of NMDA receptor antagonists was correlated with a decrease in seizure burden. Chronic treatment of homozygous mouse pups with NMDA receptor antagonists significantly delayed the onset of lethal seizures but did not prevent them. These studies illustrate the power of using multiple experimental modalities to model and test therapies for severe neurodevelopmental disorders, while revealing significant biological complexities associated with GRIN2A developmental and epileptic encephalopathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awaa147

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 78

Metadata

Authors
Amador, A., Bostick, C. D., Olson, H., Peters, J., Camp, C. R., Krizay, D., Chen, W., Han, W., Tang, W., Kanber, A., Kim, S., Teoh, J., Sah, M., Petri, S., Paek, H., Kim, A., Lutz, C. M., Yang, M., Myers, S. J., Bhattacharya, S., Yuan, H., Goldstein, D. B., Poduri, A., Boland, M. J., Traynelis, S. F., & Frankel, W. N.
Venue
Brain
Published
2020-06-24
Volume
143
Issue
7
Pages
2039-2057
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3038068929
Cited by
78
References
9
FWCI
7.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice. https://app.cochat.ai/papers/10.1093/brain/awaa147
The paper
Amador, A., Bostick, C. D., Olson, H., Peters, J., Camp, C. R., Krizay, D., Chen, W., Han, W., Tang, W., Kanber, A., Kim, S., Teoh, J., Sah, M., Petri, S., Paek, H., Kim, A., Lutz, C. M., Yang, M., Myers, S. J., . . . Frankel, W. N. (2020). Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice. Brain. https://doi.org/10.1093/brain/awaa147

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.